Navigation Links
InterCure Announces 100,000th RESPeRATE Unit Sold
Date:1/24/2008

Awareness and Adoption of Safe, Non-Drug Option to Lower Blood Pressure

Accelerates

NEW YORK, Jan. 24 /PRNewswire/ -- InterCure, Ltd. (Tel Aviv Stock Exchange: INCR) manufacturer of the RESPeRATE(R) hypertension treatment device, clinically-proven to significantly lower blood pressure, today announced it sold its 100,000th RESPeRATE device during the 2007 holiday season. This milestone marks a period of widespread consumer adoption and physician support for the novel technology and provides strong momentum for the RESPeRATE launch into retail pharmacies planned for later this year.

It took approximately four years to generate the first 50,000 unit sales of RESPeRATE, as clinical evidence, physician advocacy and consumer awareness began to take hold following the OTC clearance of the device. The second 50,000 units were sold in just 15 months. Growth is being driven through increased traction in the U.S. direct-to-consumer and online retail channels.

RESPeRATE has driven record volume through the world's leading e-commerce provider, Amazon.com, providing insight into the brand's sales potential within the retail environment. "RESPeRATE was among the top 100 items in our health and personal care store this holiday season," said Brett Barrilleaux, senior buyer at Amazon.com. "The brand's growth this year underscores our shoppers' desire for non-drug solutions in hypertension management."

"InterCure is experiencing robust growth in our core direct-to-consumer and online retail businesses. This reflects the growing consumer adoption rate for the RESPeRATE device and will serve us well as we expand our distribution into chain drugstores," said Erez Gavish, president and CEO of InterCure, manufacturer of the RESPeRATE device. "This year, we have been able to lay a solid foundation for our next phase of growth. Our traditional DTC business is healthier than it has ever been, and we have now assembled a world
'/>"/>

SOURCE InterCure, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
2. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
3. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
4. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
5. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
6. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
7. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
8. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
9. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
10. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
11. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Nuclear medicine market is estimated to ... Nuclear are drugs that contain radionuclide-emitting ionization radiation, ... and treat diseases. Increasing incidences of ... and ready availability of radiopharmaceuticals are the major ... awareness and use of SPECT and PET also ...
(Date:9/23/2014)...  SI-BONE, Inc., a medical device company that pioneered ... a minimally invasive surgical (MIS) device indicated for fusion ... U.S. Patent and Trademark Office has awarded the company ... fixation and fusion of bone.  This newly issued patent ... may be placed from one bone across a joint ...
(Date:9/23/2014)... , Sept. 23, 2014   LabStyle Innovations ... Diabetes Management Solution, today announced that it has ... of shares of preferred stock and warrants.  No ... estimated offering expenses, LabStyle expects to secure net ... LabStyle intends to use the ...
Breaking Medicine Technology:Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019) 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 2LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 3LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 4LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 5
... Use of,a low profile PressureWire yields a ... to catheter-derived pressure gradient,(CPG) measurements, according to a ... Vol. 20, Issue 1: 63-65)., The authors ... a,catheter and PressureWire correlated with anatomic stenosis, PressureWire,gradient ...
... 27 Puroast(R) Low Acid Coffee,has conducted both ... its great tasting, gourmet coffee provides symptom relief ... brew. Puroast(R) achieves,this without extractions, substitutes or additives; ... full-bodied taste., Prior chemistry research at University ...
Cached Medicine Technology:Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report 2Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report 3Low Acid Coffee Backed By Scientific Research 2
(Date:9/23/2014)... (September 23, 2014) Both patients and healthcare ... computed tomography (CT) colonography greatly outweighs the potential ... precipitated by false-positive diagnoses, according to a new ... journal Radiology . , Diagnostic tests used ... organ. However, when screening for colorectal cancer with ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Trevera ... services market. Included are Oracle Managed Services ... Trevera supports all versions of Oracle E-Business Databases ... releases. , Trevera has announced a significant ... that need help with their software technology management, ...
(Date:9/23/2014)... September 23, 2014 The Sloane ... in Singapore and Malaysia providing advanced aesthetic dermatology ... powder to its impressive skin care repertoire. Specially ... skin’s defences against the evil forces of aging, ... glow simultaneously, this new addition is revolutionizing the ...
(Date:9/23/2014)... NC (PRWEB) September 23, 2014 ... a national research university located In the Piedmont ... joined UNCG as co-director of the Center for ... bioanalytical chemistry, comes to UNCG after nearly a ... Northwest National Laboratory, Biological Sciences Division. , ...
(Date:9/23/2014)... HealthDay Reporter MONDAY, ... marches demanding action on climate change, a new study ... the United States may soon exacerbate many existing health ... illnesses are expected to increase as the number of ... Patz, director of the Global Health Institute at the ...
Breaking Medicine News(10 mins):Health News:Patients accept false-positives to achieve diagnostic sensitivity 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:Former Department of Energy Scientist Joins UNCG as Co-director of Biomedical Research Center 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3
... development of autism in infants, comparing the behavior of the ... developing normally, has found that the nascent symptoms of the ... communicative babbling are not present at 6 months, but ... of the first year of life. Researchers conducted the ...
... have identified a mechanism used by the tuberculosis bacterium ... a compound that blocks the bacterium,s ability to survive ... to treat tuberculosis. Zhong-Yin Zhang, Ph.D., Robert A. ... and Molecular Biology, and his colleagues revealed the biochemical ...
... , Feb. 15 In just two weeks, online ... helping the organization come in first with more than 49 percent ... the Super Love Sender giving campaign on the Target Facebook® page. ... on February 14, 2010 , invited the online community and ...
... (OHRI) and the University of Ottawa suggests that stem cells ... tissue development. The study, published in Proceedings of the ... researchers think about tissue development, stem cells and cancer. ... all our genes. Certain chemicals and UV light can break ...
... finds , MONDAY, Feb. 15 (HealthDay News) --People who think ... of cigarettes are kidding themselves, a new study shows. , ... Dr. R. Graham Barr, assistant professor of medicine and epidemiology ... report in the Feb. 16 issue of Annals of ...
... effect on squamous cell carcinoma , MONDAY, Feb. 15 ... of NSAID painkillers might help reduce cancer risk, a ... protection against a common skin cancer. , Previous research ... such over-the counter medications as Advil, Motrin, aspirin, Celebrex ...
Cached Medicine News:Health News:Autism's earliest symptoms not evident in children under 6 months 2Health News:Autism's earliest symptoms not evident in children under 6 months 3Health News:Autism's earliest symptoms not evident in children under 6 months 4Health News:IU research team discovers TB disease mechanism and molecule to block it 2Health News:Fans Spread the Love on Target Facebook Page and Help Donate $1 Million to Five Charities 2Health News:Fans Spread the Love on Target Facebook Page and Help Donate $1 Million to Five Charities 3Health News:Fans Spread the Love on Target Facebook Page and Help Donate $1 Million to Five Charities 4Health News:New study suggests stem cells sabotage their own DNA to produce new tissues 2Health News:Cigars, Pipes No 'Healthy' Alternative to Cigarettes 2Health News:Cigars, Pipes No 'Healthy' Alternative to Cigarettes 3Health News:NSAIDs Won't Shield Against Skin Cancer 2Health News:NSAIDs Won't Shield Against Skin Cancer 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: